Suchergebnisse - "Sisk, Robert"

PubPharm (6)

1

INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS : Ten-Year Follow-Up

enthalten in: Retina (Philadelphia, Pa.) | 2022

von Dudenhoefer, N. | Noble, C. | Petersen, M. | +5

2

EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

enthalten in: Retina (Philadelphia, Pa.) | 2019

von Sisk, R. | Rusia, D. | Zamora, B. | +2

CommentIn: Retina. 2019 Nov;39(11):e47. - PMID 30845021

3

Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases

enthalten in: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2015

von Henry, C. | Sisk, R. | Tzu, J. | +4

4

Cost comparison of intravitreal aflibercept with bevacizumab and ranibizumab for the treatment of wet age-related macular degeneration

enthalten in: Ophthalmic surgery, lasers & imaging retina | 2015

von Shaikh, A. | Toussaint, B. | Miller, D. | +5

5

Planned preterm delivery and treatment of retinal neovascularization in Norrie disease

enthalten in: Ophthalmology | 2014

von Sisk, R. | Hufnagel, R. | Bandi, S. | +2

6

Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis

enthalten in: Ophthalmology | 2012

von Cionni, D. | Lewis, S. | Petersen, M. | +5

1
[1]